It’s the last call for entries to the Cambridge Independent Science and Technology Awards 2025. With 15 categories available ...
JPMorgan raised the firm’s price target on Ascendis Pharma (ASND) to $167 from $165 and keeps an Overweight rating on the shares. The analyst ...
AstraZeneca PLC closed 16.10% below its 52-week high of £133.88, which the company reached on September 3rd.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback